Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Health
Results: 3769-3780 of 4013
Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer
AlphaBiolabs: Leading testing laboratory launches the most powerful DNA relationship test available
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions
Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award
World Mental Health Day: Young people are more stressed about their finances than they are about social issues or climate change
Centrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelona
XNK Therapeutics receives funding from Sweden's innovation agency Vinnova
Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials
Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay
Kaneka Files Patent Infringement Lawsuit Against CoCrystal
Hansa Biopharma announces encouraging high-level results for first-in-human trial of HNSA-5487
Prev
Page
1
2
…
314
315
316
…
334
335
Next
Page
